TRACKING CHANGE IN THE GLOBAL INVESTIGATIVE SITE LANDSCAPE

ABSTRACT

New benchmarks uncover a maturing and globally-shifting market During the COVID-19 pandemic, some have observed that principal investigators with minimal experience, limited infrastructure, and low study grant income have divested from clinical trial activity. The most active principal investigator segments have been growing at a much faster rate the segment comprised of those who filed between four and six form 1572s each year has grown 5.2% annually since 2010;those who filed seven or more form 1572s have grown 8.6% annually during that same period. The principal investigator segment in North America is scaling as site selection practices dictate engaging study conduct providers with more experience, infrastructure, and patient diversity.